Airflow Limitation and Survival after Surgery for Non-Small Cell Lung Cancer: results from a systematic review and lung cancer screening trial (NLST-ACRIN sub-study)

Lung cancer is one of the leading causes of cancer-related deaths in the world. In 2012, lung cancer was responsible for approximately 1.6 million deaths worldwide [1]. Lung cancer may be broadly divided into small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC), with many distinct histology subtypes in the latter [2]. In contrast to SCLC, where chemotherapy provides the mainstay of treatment with mostly palliative intent, surgery is routinely performed in early stage NSCLC with a curative intent [2,3].

Source: Lung Cancer - July 17, 2019 Category: Cancer & Oncology Authors: R.J. Hopkins, J. Ko, G.D. Gamble, R.P. Young Source Type: research